Thrombocytopenia with sodium cephalothin therapy.
D000372:Agglutination Tests; D000906:Antibodies; D001772:Blood Cell Count; D001792:Blood Platelets / Q000276:immunology; D002512:Cephalothin / Q000008:administration & dosage / Q000009:adverse effects*; D002859:Chromium Isotopes; D003298:Coombs Test; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007275:Injections, Intravenous; D007951:Leukemia, Myeloid / Q000188:drug therapy; D007958:Leukocyte Count; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy; D011113:Polymyxins / Q000627:therapeutic use; D012964:Sodium; D013921:Thrombocytopenia / Q000139:chemically induced*
D000906:Antibodies; D002859:Chromium Isotopes; D005839:Gentamicins; D006454:Hemoglobins; D011113:Polymyxins; D003561:Cytarabine; D012964:Sodium; D002512:Cephalothin